Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Pallister-Killian Syndrome is a complex genetic disorder requiring coordinated care and genetic counseling.

Oral lichen planus can appear before lichen planopilaris.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Platelet-rich plasma might be a new way to treat lichen planopilaris.

A standardized consent form for PRP injections improves patient trust and legal protection.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

The document concludes that treatment improved skin lesions but not scalp hair loss in two patients with Graham-Little-Piccardi-Lassueur syndrome.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.

A specific mutation in PA-PLA1α causes abnormal hair growth.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Arabidopsis PCaP2 helps plants survive drought by linking ABA and SA signals.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

A positive anagen pull test can help detect active Lichen Planopilaris.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

A young man was diagnosed with a rare hair loss condition usually seen in older women.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

A legally valid consent form for PRP injections was created to improve communication and protect against lawsuits.

LPA 4 helps control blood and lymph vessel development in zebrafish.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

PLA nanoparticles can effectively deliver treatments to hair follicles, showing potential for hair therapy.

Treat active lichen planopilaris early to prevent permanent hair loss.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Super-activated platelet lysate significantly promotes hair regrowth in mice with androgenetic alopecia.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.